2023
Ecological drivers of sustained enzootic yellow fever virus transmission in Brazil, 2017–2021
Silva N, Albery G, Arruda M, Oliveira G, Costa T, de Mello É, Moreira G, Reis E, da Silva S, Silva M, de Almeida M, Becker D, Carlson C, Vasilakis N, Hanley K, Drumond B. Ecological drivers of sustained enzootic yellow fever virus transmission in Brazil, 2017–2021. PLOS Neglected Tropical Diseases 2023, 17: e0011407. PMID: 37276217, PMCID: PMC10270639, DOI: 10.1371/journal.pntd.0011407.Peer-Reviewed Original ResearchConceptsMinas Gerais StateYF virus infectionNon-human primatesYF virusHigher virus titersFree-living non-human primatesInfection intensityExposure to vectorsSylvatic yellow feverEnzootic cycleViral replication levelsHigh virus dosesNon-human primate infectionCarcassYellow feverSeasonVirus titersVirus doseVirus transmissionSoutheastern BrazilVirus infectionViral strainsInfection
2000
Expression of Human Immunodeficiency Virus Type 1 Gag Protein Precursor and Envelope Proteins from a Vesicular Stomatitis Virus Recombinant: High-Level Production of Virus-like Particles Containing HIV Envelope
Haglund K, Forman J, Kräusslich H, Rose J. Expression of Human Immunodeficiency Virus Type 1 Gag Protein Precursor and Envelope Proteins from a Vesicular Stomatitis Virus Recombinant: High-Level Production of Virus-like Particles Containing HIV Envelope. Virology 2000, 268: 112-121. PMID: 10683333, DOI: 10.1006/viro.1999.0120.Peer-Reviewed Original ResearchMeSH KeywordsAIDS VaccinesAnimalsCell LineDNA, RecombinantGene Products, gagGenetic VectorsHIV Envelope Protein gp120HIV-1HumansMembrane GlycoproteinsMicroscopy, ElectronPlasmidsProtein PrecursorsRecombinant Fusion ProteinsVaccines, AttenuatedVesicular stomatitis Indiana virusViral Envelope ProteinsVirionConceptsHIV virus-like particlesVirus-like particlesEnv proteinHIV-1HIV-1 envelope proteinAntibody-mediated immunityHigh-level productionRecombinant vesicular stomatitis virusVSV particlesHIV Env proteinEnvelope proteinEffective vaccine vectorHIV-like particlesProtein precursorHIV envelopeHigh-level expression vectorVaccine vectorHIV recombinantsVesicular stomatitis virusVirus titersVirus recombinantsVSV G proteinG proteinsStomatitis virusExpression vector
1996
Effect of Stavudine on Human Immunodeficiency Virus Type 1 Virus Load as Measured by Quantitative Mononuclear Cell Culture, Plasma RNA, and Immune Complex-Dissociated Antigenemia
Griffith B, Brett-Smith H, Kim G, Mellors J, Chacko T, Garner R, Cheng Y, Alcabes P, Friedland G. Effect of Stavudine on Human Immunodeficiency Virus Type 1 Virus Load as Measured by Quantitative Mononuclear Cell Culture, Plasma RNA, and Immune Complex-Dissociated Antigenemia. The Journal Of Infectious Diseases 1996, 173: 1252-1255. PMID: 8627080, DOI: 10.1093/infdis/173.5.1252.Peer-Reviewed Original ResearchConceptsAntiviral effectHuman immunodeficiency virus type 1Peripheral blood mononuclear cellsImmunodeficiency virus type 1Effects of stavudineWeeks of therapyTime pointsBaseline median valuesBlood mononuclear cellsMononuclear cell culturesVirus type 1Antigen levelsMononuclear cellsPolymerase chain reactionVirus loadPlasma RNAWeek 4Baseline valuesImmune complexesStavudineVirus titersType 1Chain reactionPatientsTherapy
1991
Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype.
Brownstein D, Smith A, Jacoby R, Johnson E, Hansen G, Tattersall P. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Laboratory Investigation 1991, 65: 357-64. PMID: 1653878.Peer-Reviewed Original ResearchConceptsViral capsid antigenH miceInfectious virus titersB6 miceMVMi infectionCapsid antigenLethal infectionVirus titersPathogenesis of infectionBALB/cStrains of miceMinute virusAccelerated involutionSitu hybridizationC57BL/6 miceAsymptomatic infectionIntestinal hemorrhageNeonatal micePapillary hemorrhageDBA/2 miceC3H miceTarget organsVirus titrationVirus replicationGenetic susceptibility
1975
The American Burkitt Lymphoma Registry: a progress report.
LEVINE P, CHO B, CONNELLY R, BERARD C, O'CONOR G, DORFMAN R, EASTON J, DeVITA V. The American Burkitt Lymphoma Registry: a progress report. Annals Of Internal Medicine 1975, 83: 31-6. PMID: 1147436, DOI: 10.7326/0003-4819-83-1-31.Peer-Reviewed Original ResearchConceptsLymphoma RegistryAfrican patientsAmerican patientsBurkitt's lymphomaEpstein-Barr virus titersPeripheral lymph node involvementAbrupt clinical presentationEpstein-Barr virus genomeHigh-dose cyclophosphamideLymph node involvementAmerican Burkitt's lymphomaCentral nervous systemPredominance of menPathologic reviewClinical presentationLymphocytic lymphomaAbsence of casesNonendemic regionsGastrointestinal tractNervous systemLymphomaPatientsVirus titersMore casesTime-space clustering
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply